Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 4
2012 6
2013 37
2014 155
2015 245
2016 338
2017 325
2018 318
2019 150
2020 17
Text availability
Article attribute
Article type
Publication date

Search Results

1,371 results
Results by year
Filters applied: . Clear all
Page 1
Sofosbuvir/Velpatasvir (Epclusa) for Hepatitis C.
Sokol R. Sokol R. Am Fam Physician. 2017 May 15;95(10):664-666. Am Fam Physician. 2017. PMID: 28671408 Free article. No abstract available.
Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis.
Esteban R, Pineda JA, Calleja JL, Casado M, Rodríguez M, Turnes J, Morano Amado LE, Morillas RM, Forns X, Pascasio Acevedo JM, Andrade RJ, Rivero A, Carrión JA, Lens S, Riveiro-Barciela M, McNabb B, Zhang G, Camus G, Stamm LM, Brainard DM, Subramanian GM, Buti M. Esteban R, et al. Gastroenterology. 2018 Oct;155(4):1120-1127.e4. doi: 10.1053/j.gastro.2018.06.042. Epub 2018 Jun 27. Gastroenterology. 2018. PMID: 29958855 Clinical Trial.
Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.
Caldeira D, Rodrigues FB, Duarte MM, Sterrantino C, Barra M, Gonçalves N, Pinto FJ, Ferreira JJ, Costa J. Caldeira D, et al. Drug Saf. 2018 Jan;41(1):77-86. doi: 10.1007/s40264-017-0586-2. Drug Saf. 2018. PMID: 28786035 Review.
Sofosbuvir as treatment against dengue?
Gan CS, Lim SK, Chee CF, Yusof R, Heh CH. Gan CS, et al. Chem Biol Drug Des. 2018 Feb;91(2):448-455. doi: 10.1111/cbdd.13091. Epub 2017 Sep 13. Chem Biol Drug Des. 2018. PMID: 28834304
Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients.
Agarwal K, Castells L, Müllhaupt B, Rosenberg WMC, McNabb B, Arterburn S, Camus G, McNally J, Stamm LM, Brainard DM, Mani Subramanian G, Mariño Z, Dufour JF, Forns X. Agarwal K, et al. J Hepatol. 2018 Sep;69(3):603-607. doi: 10.1016/j.jhep.2018.05.039. Epub 2018 Jun 8. J Hepatol. 2018. PMID: 29886154 Clinical Trial.
Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.
Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM, Brainard DM, McHutchison JG, Mochida S, Mizokami M. Izumi N, et al. Hepatol Int. 2018 Jul;12(4):356-367. doi: 10.1007/s12072-018-9878-6. Epub 2018 Jul 20. Hepatol Int. 2018. PMID: 30030720 Free PMC article. Clinical Trial.
Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis.
Ahmed H, Abushouk AI, Attia A, Gadelkarim M, Gabr M, Negida A, Abdel-Daim MM. Ahmed H, et al. J Infect Public Health. 2018 Mar-Apr;11(2):156-164. doi: 10.1016/j.jiph.2017.09.004. Epub 2017 Sep 29. J Infect Public Health. 2018. PMID: 28970099 Free article. Review.
1,371 results
Jump to page
Feedback